{"title":"抗癌药物开发进展的几种途径","authors":"D. Lu, Yi Lu","doi":"10.15406/ncoaj.2022.08.00244","DOIUrl":null,"url":null,"abstract":"Anticancer drug development is facing increasingly challenge. Much more chemicals or bio-agents are required to be evaluated every year. High-quality and speediness of drug evaluation requires joint-efforts between chemists and pharmacologists. This Editorial provides this area of anticancer drug discovery, development and licensing.","PeriodicalId":437508,"journal":{"name":"Nursing & Care Open Access Journal","volume":"26 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Several approaches for anticancer drug development progress\",\"authors\":\"D. Lu, Yi Lu\",\"doi\":\"10.15406/ncoaj.2022.08.00244\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Anticancer drug development is facing increasingly challenge. Much more chemicals or bio-agents are required to be evaluated every year. High-quality and speediness of drug evaluation requires joint-efforts between chemists and pharmacologists. This Editorial provides this area of anticancer drug discovery, development and licensing.\",\"PeriodicalId\":437508,\"journal\":{\"name\":\"Nursing & Care Open Access Journal\",\"volume\":\"26 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nursing & Care Open Access Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15406/ncoaj.2022.08.00244\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nursing & Care Open Access Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/ncoaj.2022.08.00244","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Several approaches for anticancer drug development progress
Anticancer drug development is facing increasingly challenge. Much more chemicals or bio-agents are required to be evaluated every year. High-quality and speediness of drug evaluation requires joint-efforts between chemists and pharmacologists. This Editorial provides this area of anticancer drug discovery, development and licensing.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
